Resources
13 Results (showing 1 - 10)
Results sorted by updated date (newest first)
Results sorted by updated date (newest first)
Posted 4/3/2020 (updated 3/28/2024)
This RSV Breakout Session was held in the Independence Ballroom Salons A -C on Friday, March 6, 2020, at 9:00 AM and 11:15 AM
Posted 4/3/2020 (updated 3/28/2024)
This RSV Breakout Session was held in the Capitol Room on Wednesday, March 5, 2020, at 2:30 PM
Posted 4/3/2020 (updated 3/28/2024)
This RSV Breakout Session was held in the Mt. Vernon Square Room on Wednesday, March 4, 2020, at 4:15 PM
Posted 7/26/2023 (updated 3/28/2024)
This session focused on FY 21 RCORP-Implementation III. Grantees received an overview of the upcoming Sustainability Plan Year 2 deliverable, including a walkthrough of the template.
Posted 7/26/2023 (updated 3/28/2024)
Using Tuckman’s model of “forming, storming, norming, and performing” to look at team growth, the speakers shared the strengths and challenges of forming and sustaining two RCORP Consortia in Eastern Virginia.
Posted 7/26/2023 (updated 3/28/2024)
This session covered how primary prevention efforts fit within each of the various stages of the Continuum of Care Model. Attendees learned how to (1) engage community stakeholders from each of the 12 sectors and (2) evidence-based practices to not only inform, but to reduce stigma and to create open dialogue as it relates to SUD.
Posted 7/26/2023 (updated 3/28/2024)
Drake Cooper partnered with JBS International, Inc. (JBS) to help grantees increase their capacity and sustainability through campaign marketing materials built to combat community stigma surrounding substance use disorder (SUD) and OUD.
Posted 7/26/2023 (updated 3/28/2024)
This presentation provided an overview of the (1) current U.S. prevalence of opioid abuse and OUD and their societal consequences, (2) impacts of the opioid epidemic on rural geographic areas and populations, (3) recent emergence of synthetic opioids (e.g., fentanyl) and xylazine in the U.S. drug supply, and (4) most empirically supported treatment for patients with OUD.
Posted 6/7/2022 (updated 3/27/2024)
This session had three presenters who covered contingency management, prevention of stimulant use for children, and peer support.
Posted 6/7/2022 (updated 3/27/2024)
Cohort-Specific Sessions/Activities and Day 2 Wrap-Up